Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.21.2
Commitments and Contingencies (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Jun. 30, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Accrued expenses $ 901,222   $ 901,222     $ 519,804  
Research and development expense 2,578,016 $ 1,042,274 7,449,869 $ 3,147,636      
WPD Product Supply Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
[custom:ProductHeldAtThirdPartyDepot-0] 655,000   655,000        
WPD Product Supply Agreement [Member] | Upfront Payment [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Due from Other Related Parties, Current 131,073   131,073        
WPD Product Supply Agreement [Member] | Pass Thru Costs [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Due from Other Related Parties, Current 262,145   262,145        
Scientific Advisory Board [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Accrued expenses 28,767   28,767        
Houston Pharmaceuticals [Member] | Technology Rights Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Accrued expenses 100,000   100,000        
Royalty income     262,500 $ 150,000      
UTMDACC [Member] | Patent And Technology License Agr [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Accrued expenses 25,766   25,766        
License fee     22,902        
Contractual obligation $ 200,000   200,000        
UTMDACC [Member] | Sponsored Research Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Contractual obligation             $ 734,000
Research and development expense     600,000        
WPD [Member] | Development Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Development Fees     $ 225,000        
Climaco [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Salary and wages         $ 525,000    
Silberman [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Salary and wages         200,000    
Picker [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Salary and wages         115,000    
Downs [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Salary and wages         $ 340,000